🔗 Share this article

Acclaimed R&B singer D’Angelo died on October 14 at age 51 after a private battle with pancreatic malignancy.

“The brilliant light of our household has faded away for us in this life,” his relatives confirmed. “After a lengthy and courageous struggle with the disease, we are heartbroken to announce that Michael D’Angelo Archer, recognized by his followers around the world as D’Angelo, has been called home.”

D’Angelo made a lasting impact on music with his pioneering neo-soul sound and partnerships with renowned musicians.

He released his debut album, “Brown Sugar,” in the mid-nineties to immediate acclaim. The record reached No. 4 on the R&B charts, went platinum soon after, and received multiple Grammy nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that propelled his artistic journey into the stratosphere. The record premiered at the top spot on both Billboard’s Top R&B Albums chart and the Billboard 200. He received two Grammy Awards: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a sex symbol, albeit a hesitant one, in the public consciousness. The personal depiction showed the singer, notably stripped down to his waist, singing directly into the lens.

D’Angelo stepped back from the public eye after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a serious vehicle accident that left him in grave health.

More than a decade later, his third and final album, “Black Messiah” (2014), confirmed his enduring appeal with a further No. 1 debut on the R&B chart and a Grammy for Best R&B Album.

Again, in his own enigmatic fashion, D’Angelo had limited public appearances in the subsequent period.

The singer was announced as a headliner for the 2025 Roots Picnic festival, but his performance was canceled, citing an “unexpected health issue.”

Even though details are sparse about D’Angelo’s health in the weeks leading up to his passing, he had apparently been in the hospital for months and in palliative care for two weeks.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic cancer, one of the deadliest and hardest to prevent forms of the disease, on a brilliant talent whose life was ended too soon.

“We are grieved that he can only provide cherished moments with his loved ones, but we are forever thankful for the legacy of deeply emotional songs he has left us,” his kin said.

Pancreatic Cancer: Lethal and Difficult to Avoid

Pancreatic malignancy impacts the pancreas, a small organ that produces the hormone insulin and is vital in breaking down food, among other functions. The position and dimensions of the pancreas in the body make it more difficult to identify cancer.

Although this cancer makes up only about 3% of malignancy cases each year in the U.S., it is responsible for 7% of cancer deaths.

Almost 70,000 people will be found to have pancreatic cancer and roughly fifty-two thousand will die of the illness in the year 2025.

“This malignancy is one of the most lethal diseases, with an fast-growing mass and dismal outcomes. We have few and ineffective therapies, and a narrow opportunity to make a significant difference on the well-being of people,” said a medical oncologist.

Because pancreatic cancer seldom produces early symptoms, it’s frequently diagnosed only once the condition is late-stage. Although a patient has indicators they are usually vague and may be confused with a number of everyday ailments.

“As of yet, there is no effective method to identify pancreatic cancer in the initial phases, apart from listening to your body and speaking with your doctor if there are unfamiliar signs,” explained a health expert.

Frequent indicators of this disease encompass:

• discomfort in the stomach or back
• reduced body mass
• jaundice
• reduced hunger
• brownish urine
• light-colored or greasy stools
• loose stools
• excessive hunger or thirst
• nausea

At age 51, D’Angelo’s demise is an exception, as pancreatic cancer is most common in adults in the 65 to 75 age bracket. However, numerous malignancies, such as this type, have become increasingly prevalent in younger people.

“Pancreatic cancer diagnosed before the age of 50 is deemed uncommon, yet alarmingly, clinicians are beginning to see a rising count of younger individuals suffering from this disease,” said a expert.

Family History Impacts Cancer Risk

Without reliable detection methods for pancreatic cancer, professionals stressed the importance of understanding your relatives’ health background. Certain risk factors, such as tobacco use and obesity also have an influence in the onset of this disease.

Black individuals have the greatest occurrence of pancreatic cancer in the United States and are more prone to be found to have untreatable disease.

“The initial action toward reducing one’s chance of pancreatic cancer is assessing personal risk factors. People should review their family history, hereditary factors, and health issues, such as diabetes, chronic pancreatitis, or obesity that may increase their vulnerability,” advised a medical professional.

Inherited genetic elements are linked to as much as ten percent of all pancreatic cancer cases. If someone in your family has had this disease, you may want to consider genetic testing.

“For individuals with a relative’s background of pancreatic cancer or those having high risk DNA changes, screening may involve advanced imaging such as MRI scans or internal ultrasound to detect initial alterations in the organ,” he clarified.

For those wishing to lower their chance, lifestyle changes may have an effect. The best step you can take to lower your risk of this disease is to quit smoking, and if you are a non-smoker, avoid exposure altogether.

Excessive drinking is linked to pancreatitis, a risk factor for this malignancy, so reducing or avoiding drinks may help lower your chance.

Controlling your body mass or losing weight may also aid decrease your susceptibility. People with obesity are twenty percent more prone to get pancreatic cancer. Pancreatic cancer also is more frequent in those with blood sugar issues, and reducing weight can also lower the chance of type 2 diabetes.

In spite of pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are making progress with therapies and newer mixed drug treatments. There are developing targeted therapies that are already showing results,” remarked a expert.

For numerous people, however, awareness about this uncommon but {dev